1. Home
  2. BCTX vs WCT Comparison

BCTX vs WCT Comparison

Compare BCTX & WCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCTX
  • WCT
  • Stock Information
  • Founded
  • BCTX 2014
  • WCT 2012
  • Country
  • BCTX Canada
  • WCT Hong Kong
  • Employees
  • BCTX N/A
  • WCT N/A
  • Industry
  • BCTX Biotechnology: Pharmaceutical Preparations
  • WCT
  • Sector
  • BCTX Health Care
  • WCT
  • Exchange
  • BCTX Nasdaq
  • WCT NYSE
  • Market Cap
  • BCTX 16.1M
  • WCT 13.9M
  • IPO Year
  • BCTX N/A
  • WCT 2024
  • Fundamental
  • Price
  • BCTX $3.41
  • WCT $0.29
  • Analyst Decision
  • BCTX Strong Buy
  • WCT
  • Analyst Count
  • BCTX 1
  • WCT 0
  • Target Price
  • BCTX $32.00
  • WCT N/A
  • AVG Volume (30 Days)
  • BCTX 791.2K
  • WCT 1.2M
  • Earning Date
  • BCTX 06-13-2025
  • WCT 05-16-2025
  • Dividend Yield
  • BCTX N/A
  • WCT N/A
  • EPS Growth
  • BCTX N/A
  • WCT N/A
  • EPS
  • BCTX N/A
  • WCT N/A
  • Revenue
  • BCTX N/A
  • WCT $2,309,218.00
  • Revenue This Year
  • BCTX N/A
  • WCT N/A
  • Revenue Next Year
  • BCTX N/A
  • WCT N/A
  • P/E Ratio
  • BCTX N/A
  • WCT N/A
  • Revenue Growth
  • BCTX N/A
  • WCT N/A
  • 52 Week Low
  • BCTX $2.81
  • WCT $0.12
  • 52 Week High
  • BCTX $29.40
  • WCT $9.36
  • Technical
  • Relative Strength Index (RSI)
  • BCTX 47.56
  • WCT N/A
  • Support Level
  • BCTX $2.81
  • WCT N/A
  • Resistance Level
  • BCTX $3.69
  • WCT N/A
  • Average True Range (ATR)
  • BCTX 0.28
  • WCT 0.00
  • MACD
  • BCTX 0.06
  • WCT 0.00
  • Stochastic Oscillator
  • BCTX 65.93
  • WCT 0.00

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.

About WCT WELLCHANGE HOLDINGS COMPANY LIMITED

Wellchange Holdings Co Ltd is an enterprise software solution services provider. It provides software solutions, cloud-based software-as-a-service (SaaS) platforms, and white-label software design and development services.

Share on Social Networks: